Wall Street Zen Upgrades Guardian Pharmacy Services (NYSE:GRDN) to “Buy”

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, Wall Street Zen reports.

A number of other research firms have also recently commented on GRDN. KeyCorp began coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 target price on the stock. Weiss Ratings raised shares of Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a report on Monday, September 21st. Finally, Oppenheimer lifted their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research note on Friday, August 7th. Nine investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Guardian Pharmacy Services has a consensus rating of “Moderate Buy” and a consensus price target of $45.57.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services stock opened at $39.34 on Friday. The firm has a market capitalization of $1.96 billion, a PE ratio of 38.19, a price-to-earnings-growth ratio of 2.06 and a beta of 0.03. Guardian Pharmacy Services has a one year low of $23.72 and a one year high of $48.33. The stock’s 50 day moving average price is $40.83 and its 200 day moving average price is $39.89.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.03. The company had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. On average, analysts forecast that Guardian Pharmacy Services will post 1.18 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. State of Alaska Department of Revenue boosted its holdings in Guardian Pharmacy Services by 105.9% in the third quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after purchasing an additional 1,229 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Guardian Pharmacy Services by 3.2% during the 1st quarter. Bank of New York Mellon Corp now owns 69,432 shares of the company’s stock worth $2,615,000 after purchasing an additional 2,177 shares during the last quarter. Arizona State Retirement System increased its holdings in Guardian Pharmacy Services by 53.0% during the 2nd quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock worth $351,000 after purchasing an additional 2,907 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in Guardian Pharmacy Services by 67.4% during the 1st quarter. The Manufacturers Life Insurance Company now owns 11,820 shares of the company’s stock worth $445,000 after purchasing an additional 4,761 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC acquired a new position in shares of Guardian Pharmacy Services in the 1st quarter valued at approximately $253,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc (NYSE: GRDN) is a healthcare services company that provides pharmacy services to residents of long-term care and other institutional healthcare settings. Its customers include assisted living communities, skilled nursing facilities, behavioral health centers and communities serving individuals with developmental disabilities.

The company’s services include prescription dispensing, medication packaging and delivery, medication management, pharmacy consulting and clinical support.